GB201509827D0 - Antibody drug conjugate for treatment of cancer - Google Patents

Antibody drug conjugate for treatment of cancer

Info

Publication number
GB201509827D0
GB201509827D0 GBGB1509827.0A GB201509827A GB201509827D0 GB 201509827 D0 GB201509827 D0 GB 201509827D0 GB 201509827 A GB201509827 A GB 201509827A GB 201509827 D0 GB201509827 D0 GB 201509827D0
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
drug conjugate
antibody drug
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1509827.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dublin City University
Original Assignee
Dublin City University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dublin City University filed Critical Dublin City University
Priority to GBGB1509827.0A priority Critical patent/GB201509827D0/en
Publication of GB201509827D0 publication Critical patent/GB201509827D0/en
Ceased legal-status Critical Current

Links

GBGB1509827.0A 2015-06-05 2015-06-05 Antibody drug conjugate for treatment of cancer Ceased GB201509827D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1509827.0A GB201509827D0 (en) 2015-06-05 2015-06-05 Antibody drug conjugate for treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1509827.0A GB201509827D0 (en) 2015-06-05 2015-06-05 Antibody drug conjugate for treatment of cancer

Publications (1)

Publication Number Publication Date
GB201509827D0 true GB201509827D0 (en) 2015-07-22

Family

ID=53785050

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1509827.0A Ceased GB201509827D0 (en) 2015-06-05 2015-06-05 Antibody drug conjugate for treatment of cancer

Country Status (1)

Country Link
GB (1) GB201509827D0 (en)

Similar Documents

Publication Publication Date Title
PT3616720T (en) Pharmaceutical composition for cancer treatment
HK1245134A1 (en) Treatment of cancer with anti-lap monoclonal antibodies
IL264674B1 (en) Anti-siglec-7 antibodies for the treatment of cancer
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
IL249231A0 (en) Pharmaceutical combinations for treating cancer
LT3473263T (en) Combined preparations for the treatment of cancer
SG11202104923YA (en) Pharmaceutical combination for treatment of cancer
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
EP3304076A4 (en) Methods for determining drug efficacy for treatment of cancer using ratios of cereblon associated proteins
ZA201900052B (en) Pharmaceutical combinations for treating cancer
HK1222548A1 (en) Pharmaceutical combinations for the treatment of cancer
IL259569A (en) Salts of conjugates for cancer therapy
IL268416A (en) Pharmaceutical combinations for treating cancer
IL263835A (en) Exosome-guided treatment of cancer
IL261278A (en) Pharmaceutical compositions for the treatment of cancer
EP3289084A4 (en) siRNA INHIBITION OF HUMAN ANTIGEN R EXPRESSION FOR TREATMENT OF CANCER
IL275525A (en) Pharmaceutical composition for the treatment of cancer
IL270140B (en) Therapeutic agent for blood cancer
GB201509827D0 (en) Antibody drug conjugate for treatment of cancer
GB201713936D0 (en) Pharmaceutical combinations for the treatment of cancer
EP3441465A4 (en) Cancer treatment pharmaceutical composition using anti-mct5 antibody
GB201622214D0 (en) treatment of cancer
GB201604621D0 (en) Treatment of cancer
GB201604293D0 (en) Treatment of cancer
IL236381A0 (en) Pharmaceutical compositions for treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)